
Hematology-Oncologybiomarker-driven treatmentclinical trials
Navigating the Therapeutic Complexity in Large B-Cell Lymphoma: Toward Harmonized First-Line Trial Designs
By MedXY|Oct 9, 2026
Emerging therapies have revolutionized first-line treatment in large B-cell lymphoma, but inconsistent trial designs and biomarker use create complexity. Harmonized strategies integrating biomarkers, pooled data, AI, and regulatory collabor
